Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGGF1P6, Angiogenic factor with G-patch and FHA domains 1 pseudogene 6, is a processed pseudogene found in humans, corresponding to a nonfunctional copy of the AGGF1 gene. Like other pseudogenes, AGGF1P6 does not encode a functional protein due to sequence alterations acquired after duplication or retrotransposition. While some pseudogenes may have regulatory roles at the RNA level, such as acting as microRNA “decoys” or antisense modulators, there is no current evidence of such a function for AGGF1P6 specifically. AGGF1P6 is not recognized as a therapeutic target, nor is it involved in any known disease mechanism or used as a biomarker. Its clinical relevance is mainly limited to genomic studies and as a reference in bioinformatics analyses, since the presence of pseudogenes can complicate interpretation of next-generation sequencing data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenic factor with G-patch and FHA domains 1 pseudogene 6 (AGGF1P6).